Search Results
Staff
William J. Pavan, Ph.D. is the chief of NHGRI's Genetic Disease Research Branch.
… therapeutic compounds via high-throughput screens, its Therapeutics for Rare and Neglected Diseases program to …
Staff
Antwi-Boasiako Oteng is a Research Fellow at the Center for Research on Genomics and Global Health.
News Release
The U.S. Food and Drug Administration has approved the first treatment for progeria, a rare and fatal pediatric disease, characterized by dramatic, rapid aging beginning in childhood.
News Release
NIH researchers identified a novel role for a gene known as heat shock protein 60, finding it is critical in tissue regeneration and wound healing.
… their colleagues, may help in the development of effective therapeutics for accelerating wound closure in diabetic …
News Release
NIH investigators have discovered that genomic switches of a blood cell are key to regulating the human immune system.
Staff
Abdel Elkahloun is an associate investigator in NHGRI's Office of Scientific Core Facilities.
Staff
Dr. Introne is a pediatrician, clinical and biochemical geneticist in the Medical Genetics Branch in NHGRI.
Event
A joint NHGRI-NCATS hosted meeting bringing together researchers, clinicians, families and patient advocates from around the world to discuss the natural history, disease pathophysiology, genetics and treatments for rare inborn metabolic errors.
… 3 Elizabeth Ottinger, Ph.D. Head of Project Management, Therapeutics Development Branch, NCATS 2:30 - 2:50 p.m. …
Research Funding
The Knockout Mouse Phenotyping Project (KOMP2) collaborates with the International Mouse Phenotyping Consortium (IMPC) to knockout and characterize all protein-coding genes in the mouse genome.
Staff
Dr. James Inglese is an adjunct investigator in NHGRI's Metabolic Medicine Branch.